Cargando…
γH2AX, a DNA Double-Strand Break Marker, Correlates with PD-L1 Expression in Smoking-Related Lung Adenocarcinoma
In recent years, the choice of immune checkpoint inhibitors (ICIs) as a treatment based on high expression of programmed death-ligand 1 (PD-L1) in lung cancers has been increasing in prevalence. The high expression of PD-L1 could be a predictor of ICI efficacy as well as high tumor mutation burden (...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223793/ https://www.ncbi.nlm.nih.gov/pubmed/35743122 http://dx.doi.org/10.3390/ijms23126679 |
_version_ | 1784733212892725248 |
---|---|
author | Sakurai, Eiko Ishizawa, Hisato Kiriyama, Yuka Michiba, Ayano Hoshikawa, Yasushi Tsukamoto, Tetsuya |
author_facet | Sakurai, Eiko Ishizawa, Hisato Kiriyama, Yuka Michiba, Ayano Hoshikawa, Yasushi Tsukamoto, Tetsuya |
author_sort | Sakurai, Eiko |
collection | PubMed |
description | In recent years, the choice of immune checkpoint inhibitors (ICIs) as a treatment based on high expression of programmed death-ligand 1 (PD-L1) in lung cancers has been increasing in prevalence. The high expression of PD-L1 could be a predictor of ICI efficacy as well as high tumor mutation burden (TMB), which is determined using next-generation sequencing (NGS). However, a great deal of effort is required to perform NGS to determine TMB. The present study focused on γH2AX, a double-strand DNA break marker, and the suspected positive relation between TMB and γH2AX was investigated. We assessed the possibility of γH2AX being an alternative marker of TMB or PD-L1. One hundred formalin-fixed, paraffin-embedded specimens of lung cancer were examined. All of the patients in the study received thoracic surgery, having been diagnosed with lung adenocarcinoma or squamous cell carcinoma. The expressions of γH2AX and PD-L1 (clone: SP142) were evaluated immunohistochemically. Other immunohistochemical indicators, p53 and Ki-67, were also used to estimate the relationships of γH2AX. Positive relationships between γH2AX and PD-L1 were proven, especially in lung adenocarcinoma. Tobacco consumption was associated with higher expression of γH2AX, PD-L1, Ki-67, and p53. In conclusion, the immunoexpression of γH2AX could be a predictor for the adaptation of ICIs as well of as PD-L1 and TMB. |
format | Online Article Text |
id | pubmed-9223793 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92237932022-06-24 γH2AX, a DNA Double-Strand Break Marker, Correlates with PD-L1 Expression in Smoking-Related Lung Adenocarcinoma Sakurai, Eiko Ishizawa, Hisato Kiriyama, Yuka Michiba, Ayano Hoshikawa, Yasushi Tsukamoto, Tetsuya Int J Mol Sci Article In recent years, the choice of immune checkpoint inhibitors (ICIs) as a treatment based on high expression of programmed death-ligand 1 (PD-L1) in lung cancers has been increasing in prevalence. The high expression of PD-L1 could be a predictor of ICI efficacy as well as high tumor mutation burden (TMB), which is determined using next-generation sequencing (NGS). However, a great deal of effort is required to perform NGS to determine TMB. The present study focused on γH2AX, a double-strand DNA break marker, and the suspected positive relation between TMB and γH2AX was investigated. We assessed the possibility of γH2AX being an alternative marker of TMB or PD-L1. One hundred formalin-fixed, paraffin-embedded specimens of lung cancer were examined. All of the patients in the study received thoracic surgery, having been diagnosed with lung adenocarcinoma or squamous cell carcinoma. The expressions of γH2AX and PD-L1 (clone: SP142) were evaluated immunohistochemically. Other immunohistochemical indicators, p53 and Ki-67, were also used to estimate the relationships of γH2AX. Positive relationships between γH2AX and PD-L1 were proven, especially in lung adenocarcinoma. Tobacco consumption was associated with higher expression of γH2AX, PD-L1, Ki-67, and p53. In conclusion, the immunoexpression of γH2AX could be a predictor for the adaptation of ICIs as well of as PD-L1 and TMB. MDPI 2022-06-15 /pmc/articles/PMC9223793/ /pubmed/35743122 http://dx.doi.org/10.3390/ijms23126679 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sakurai, Eiko Ishizawa, Hisato Kiriyama, Yuka Michiba, Ayano Hoshikawa, Yasushi Tsukamoto, Tetsuya γH2AX, a DNA Double-Strand Break Marker, Correlates with PD-L1 Expression in Smoking-Related Lung Adenocarcinoma |
title | γH2AX, a DNA Double-Strand Break Marker, Correlates with PD-L1 Expression in Smoking-Related Lung Adenocarcinoma |
title_full | γH2AX, a DNA Double-Strand Break Marker, Correlates with PD-L1 Expression in Smoking-Related Lung Adenocarcinoma |
title_fullStr | γH2AX, a DNA Double-Strand Break Marker, Correlates with PD-L1 Expression in Smoking-Related Lung Adenocarcinoma |
title_full_unstemmed | γH2AX, a DNA Double-Strand Break Marker, Correlates with PD-L1 Expression in Smoking-Related Lung Adenocarcinoma |
title_short | γH2AX, a DNA Double-Strand Break Marker, Correlates with PD-L1 Expression in Smoking-Related Lung Adenocarcinoma |
title_sort | γh2ax, a dna double-strand break marker, correlates with pd-l1 expression in smoking-related lung adenocarcinoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223793/ https://www.ncbi.nlm.nih.gov/pubmed/35743122 http://dx.doi.org/10.3390/ijms23126679 |
work_keys_str_mv | AT sakuraieiko gh2axadnadoublestrandbreakmarkercorrelateswithpdl1expressioninsmokingrelatedlungadenocarcinoma AT ishizawahisato gh2axadnadoublestrandbreakmarkercorrelateswithpdl1expressioninsmokingrelatedlungadenocarcinoma AT kiriyamayuka gh2axadnadoublestrandbreakmarkercorrelateswithpdl1expressioninsmokingrelatedlungadenocarcinoma AT michibaayano gh2axadnadoublestrandbreakmarkercorrelateswithpdl1expressioninsmokingrelatedlungadenocarcinoma AT hoshikawayasushi gh2axadnadoublestrandbreakmarkercorrelateswithpdl1expressioninsmokingrelatedlungadenocarcinoma AT tsukamototetsuya gh2axadnadoublestrandbreakmarkercorrelateswithpdl1expressioninsmokingrelatedlungadenocarcinoma |